Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6.80M | $72.0M | 10.54% | -524.9K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.89M | $41.0M | 6.03% | -- | 2026-03-31 |
| D. E. Shaw & Co., Inc. | 3.64M | $38.0M | 5.64% | -50.6K | 2026-03-31 |
| Pfizer Inc | 3.46M | $34.0M | 5.36% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.69M | $28.0M | 4.17% | -- | 2026-03-31 |
| TCG Crossover Management, LLC | 2.39M | $25.0M | 3.70% | -278.8K | 2026-03-31 |
| ARMISTICE CAPITAL, LLC | 1.98M | $20.0M | 3.07% | +178.0K | 2026-03-31 |
| STATE STREET CORP | 1.83M | $19.0M | 2.83% | -14.9K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.56M | $16.0M | 2.41% | -66.4K | 2026-03-31 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.44M | $15.0M | 2.23% | +1.19M | 2026-03-31 |
